Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Bioorg Med Chem Lett. 2021 Apr 23;43:128061. doi: 10.1016/j.bmcl.2021.128061

Figure 6.

Figure 6.

Synergism studies using BCL inhibitors and PROTAC 2. (A) Structure of Bcl2 inhibitors Navitoclax (ABT-263); Venetoclax (ABT-199); WEHI-539; (B) Growth inhibitory effects of different inhibitors combinations at 5 μM, (C) Combination index (Cl) values for the three Bcl2 inhibitors and PROTAC 2 combinations.